Pak1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine Deposition Author(s): Gutmann, S. , Rummel, G.
Date: 2015-04-29 Method: X-RAY DIFFRACTION Resolution: 1.99 Å Organism(s): Homo Sapiens Sequences Data: 4ZJI_A , 4ZJI_B , 4ZJI_C , 4ZJI_D
Pak1 in complex with (s)-n-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide Deposition Author(s): Gutmann, S. , Rummel, G.
Date: 2015-04-29 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 4ZJJ_A , 4ZJJ_B , 4ZJJ_C , 4ZJJ_D
Discovery and pharmacological characterization of novel quinazoline-based pi3k delta-selective inhibitors Deposition Author(s): Gutmann, S. , Rummel, G. , Shrestha, B.
Date: 2016-03-15 Method: X-RAY DIFFRACTION Resolution: 2.85 Å Organism(s): Mus Musculus Sequences Data: 5IS5_A
Discovery of cdz173 (leniolisib), representing a structurally novel class of pi3k delta-selective inhibitors Deposition Author(s): Gutmann, S. , Rummel, G. , Shrestha, B.
Date: 2017-06-12 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Mus Musculus Sequences Data: 5O83_A
Pi3k delta in complex with sd5 Deposition Author(s): Gutmann, S. , Rummel, G. , Shrestha, B.
Date: 2022-02-04 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Mus Musculus Sequences Data: 7R26_A
Pi3kdelta in complex with an inhibitor Deposition Author(s): Gutmann, S. , Rummel, G. , Shrestha, B.
Date: 2022-02-04 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Mus Musculus Sequences Data: 7R2B_A